UBB+1 is present in the brain tissues of all AD patients (Ebrahimi-Fakhari et al., 2012) and co-localizes with pathological changes in Tau protein, involving the early induction of Aβ deposition and phosphorylated Tau protein aggregation in AD (Hol et al., 2005). The gene discussed is MAPT; the disease is Alzheimer disease.